ArticleFrontiers in oncology2022

HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients.

Stefano Cavalieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.